Novel activators of dendritic cells as fundamental tools in immunotherapy

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.11, Iss.9, 2001-09, pp. : 1411-1421

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV-Antigens Charged on Phosphorus Dendrimers as Tools for Tolerogenic Dendritic Cells-Based Immunotherapy

Current Medicinal Chemistry, Vol. 21, Iss. 16, 2014-05 ,pp. : 1898-1909

Bentham Science Publishers

Access to resources Recommend Favorite

Dendritic Cells in Tumor Immunology and Immunotherapy

Current Drug Targets, Vol. 5, Iss. 1, 2004-01 ,pp. : 17-39

Bentham Science Publishers

Access to resources Recommend Favorite

Dendritic cells: immunological features and utilisation for tumour immunotherapy

By Reay Philip A

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 4, 2001-08 ,pp. : 491-506

Informa Healthcare

Access to resources Recommend Favorite

Genetically Modified Dendritic Cells for Cancer Immunotherapy

Current Gene Therapy, Vol. 5, Iss. 6, 2005-12 ,pp. : 619-628

Bentham Science Publishers

Access to resources Recommend Favorite

Dendritic Cells: Activation and Maturation - Applications for Cancer Immunotherapy

Current Medicinal Chemistry, Vol. 12, Iss. 15, 2005-07 ,pp. : 1783-1800

Bentham Science Publishers

Access to resources Recommend Favorite